- Supplements Facts
- Client Reviews
Advanced for Prostate and Urinary Health.
TrueProstate™ is formulated for men over age 40 to support prostate and urinary health.
TrueProstate™ incorporates the latest findings in prostate and urinary health - and excludes some ingredients that recent research suggests aren’t worth your money.
The first key ingredient is a cranberry extract called Flowens®, which helps with in all seven measures typically assessed for prostate health:
- urinary frequency
- bladder emptying
- weak stream
- straining and
- nocturnia (having to urinate frequently at night).
These measures collectively form an index used to assess prostate and urinary health known as IPSS.
TrueProstate™ also contains AGEprostT, which is an extract of the Ageratum conbyzoides herb. This herb has been used traditionally in the Caribbean for prostate and urinary health.
AGEprost™ may help you with several prostate health measures, including helping to reduce daytime and nighttime urination frequency.
On top of this, TrueProstate™ is made with a natural source of beta sitosterol called Phytopin®, which is from pine trees in southwestern France. Phytopin® may improve IPSS scores by as much as 50%.
In addition, TrueProstate™ contains SelenoExcell® - made from high selenium yeast - which helps to protect the prostate from oxidative stress.
For futher free radical protection, the formula includes a green tea extract rich in EGCG and zinc (from TRAACS® as bisglycinate chelate).
Flowens®: The First Scientifically Backed Cranberry Ingredient for Prostate Health and Urinary Symptoms
Flowens® is a full spectrum cranberry powder extract made from North American cranberries.
Flowens® supports prostate health when taking as little as 250mg a day - and works even better at 500mg a day, which is the amount you get in TrueProstate™.
Specifically, Flowens® helps with all seven measures that make up the IPSS score and symptoms linked to BPH: urinary frequency, bladder emptying, intermittency, urgency, weak stream, straining and nocturnia (having to urinate frequently at night).
Men taking Flowens® reported benefits started after just three weeks of use.
AGEprost™: Caribbean Tradition Now Supported by Science
The herb Ageratum conbyzoides has been used traditionally in the Caribbean for prostate and urinary health for many years.
This herb contains many compounds that may help support protate health such as such as terpenoids, sterols, flavonoids, coumarins, and lignans.
AGEprost™ is the first scientifically backed extract of Ageratum conbyzoides for prostate and urinary health.
One of the ways it benefits prostate health is by helping to inhibit the enzyme, 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT).
Excessive DHT is a major cause of many prostate problems, including BPH. By helping to control 5-alpha reductase, AGEprost™ and other TrueProstate™ ingredients may help keep DHT and testosterone levels balanced.
In addition, AGEprost™ promotes urinary health by helping to relax muscles around the urethra and smooth muscles of the neck of the bladder.
AGEprost™ may help you with several prostate health measures, including helping to reduce daytime and nighttime urination frequency.
PhytoPin®: Scientifically Backed Natural Beta Sitosterol
The plant phytosterol known as beta sitosterol has been shown to both relieve symptoms of BPH and promote a healthier prostate.
The premier source of beta sitosterol is PhytoPin® - which comes from pine trees in Southwest France.
PhytoPin® is backed by two clinical studies including a "gold standard" study published in prestigious journal, The Lancet. This study is widely considered the landmark study for beta sitosterol and prostate health.
The 200 men in this study took either 60mg of natural beta sitosterol daily for 6 months or a placebo. The group taking the placebo did not experience an improvement.
On the other hand, the men taking beta sitosterol experienced about a 50% decline in IPSS scores.
On average, they improved significantly on all seven urinary flow parts of the IPSS score.
Even better, many men continued taking beta sitosterol for a total of 18 months and all the benefits were maintained for the entire period.
Moreover, a second clinical study with PhytoPin®, published in the?British Journal of Urology, used a 130mg daily serving of beta sitosterol and the results were similar to the 60mg serving - so in this case more is not necessarily better.
Why the Type of Selenium in Your Prostate Supplement Matters.
When it comes to prostate supplements, one of the most confusing and least understood aspects is the role of the mineral selenium.
Back around 1998 there was great excitement about selenium's ability to influence prostate health based on scientific results.
Importantly, the ingredient used in this research wasn't some run of the mill selenium. It was a specific brand called SelenoExcell® - which is made from high selenium yeast.
One of the unique features of SelenoExcell® is it's not a single selenium compound, it's a cluster of multiple selenium compounds bound to different amino acids - which is the way your body gets selenium from food.
For example, SelenoExcell® naturally includes selenomethionine, selenocysteine and methylselenocysteine and other forms of selenium.
More recent research has reinforced the benefits of SelenoExcell® on prostate health.
For example, researchers at Penn State performed a head-to-head test of SelenoExcell® versus selenomethionine. In this study, SelenoExcell® was found to protect the prostate from oxidative stress caused by free radicals - while selenomethionine had no impact.
On top of this, another recent study published in Environmental Science Technology, showed SelenoExcell® helps rid the body of unwanted heavy metals like mercury and cadmium over a three month period
Each serving of TrueProstate™ provides 100mcg of SelenoExcell® - which supplements the estimated 100mcg of dietary selenium consumed by the average person in a day.
Where in the Body is the Largest Concentration of Zinc?
Dietary Supplement / 90 capsules
Serving Size: 3 capsules
Servings per Container: 30
|Amount Per Serving||% Daily Value|
|Vitamin D [as Vitamin D3 (cholecalciferol)]||10 mcg (400 IU)||50%|
|Zinc (as TRAACS® zinc bisglycinate chelate)||15 mg||136%|
|Selenium (as SelenoExcell® organically bound high selenium yeast)||100 mcg||182%|
|Pumpkin seed extract (EFLA®940)||500 mg||*|
|Cranberry fruit solids (Flowens™)||500 mg||*|
|Beta Sitosterol from Pine phytosterols (Phytopin)||70 mg||*|
|Green tea leaf standardized extract (98% polyphenols, 45% EGCG)||225 mg||*|
* Daily value not established.
Other ingredients: Gelatin, rice flour, silica, stearic acid
Flowens™ is a trademark of Naturex.
EFLA® 940 is a trademark of Frutarom Switzerland.
TRAACS® is a registered trademark of Albion Laboratories, Inc.
SelenoExcell® is a registered trademark of Cypress Systems, Inc.
Phytopin® is a registered trademark of DRT.
SUGGESTED USE: Take three (3) capsules daily or as directed by your health care practitioner.
Keep out of reach of children.
Store in cool dry place
Do not use if seal is broken or missing
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Gluten Free
- Assembled in the USA
- BPA Free
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Flowens™ Cranberry Powder
Student V, Vostalova J, Vidlar A, Klejdus B, Fromentin E, Roller M, Simanek V.
Vidlar A, Vostalova J, Ulrichova J, Student V, Stejskal D, Reichenbach R, Vrbkova J, Ruzicka F, Simanek V. British Journal of Nutrition. 2010 Oct;104(8):1181-9.
Nishimura M, Ohkawara T, Sato H, Takeda H, Nishihira J. Journal of Traditional and Complementary Medicine. 2014;4(1):72-74. doi:10.4103/2225-4110.124355.
Cho YH, Lee SY, Jeong DW, et al. Evidence-based Complementary and Alternative Medicine?: eCAM. 2014;2014:549721. doi:10.1155/2014/549721.
Yadav M, Jain S, Tomar R, Prasad G, Yadav H. Nutrition Research Reviews. December 2010. Volume 23, pp 184190.
Hong H, Kim C, Maeng S. Nutrition Research and Practice. 2009 Winter; 3(4): 323–327.
Terado T, Sogabe H. Japanese Journal of Medicine and Pharmaceutical Science. 2004;52(4):551-561.
Yanagisawa Ei et al. Japanese Journal of Medicine and Pharmaceutical Science. 2003 Vol 50 (3).
Bach D. Urologe B. 2000;40:437–443.
McNicholas T, Kirby R. BMJ Clinical Evidence. 2011;2011:1801.
Coleman CI, Hebert JH, Reddy P. Pharmacotherapy. 2002 Nov;22(11):1426-32.
Preuss HG, Marcusen C, Regan J, Klimberg IW, Welebir TA, Jones WA. International Journal of Urology and Nephrology. 2001;33(2):217-25.
Awad AB, Fink CS. Journal of Nutrition. 2000 Sep;130(9):2127-30.
Berges RR, Kassen A, Senge T. British Journal of Urology International. 2000 May;85(7):842-6. PMID 10792163.
Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. BJU International. 1999. 83, 976-983.
Klippel K, Hiltl D, Schipp B. British Journal of Urology. September, 1997. Volume 80, Issue 3, 427-432.
Berges RR, Windeler J, Trampisch HJ, Senge T. The Lancet. 1995 Jun 17;345(8964):1529-32.
Fischer A, Jurincic Winkler CD, Klippel KF. Uroscop 1993; 1: 12±20.
Goodarzi D, Cyrus A, Baghinia MR, Kazemifar AM, Shirincar M. Acta Med Indones. 2013 Oct;45(4):259-64.
Christudoss P, Selvakumar R, Fleming J, Gopalakrishnan G. Indian Journal of Urology. 2011 Jan-Mar; 27(1): 14–18.
Yan M, Hardin K, Ho E. The Journal of Nutritional Biochemistry. 2010 Aug; 21(8): 687–694.
Ho E1, Song Y. Current Opinion in Clinical Nutrition and Metabolic Care. 2009 Nov;12(6):640-5.
Gonzalez A, Peters U, Lampe JW, White E. Nutrition and Cancer. March, 2009;61(2):206-15.
Gómez Y, Arocha F, Espinoza F, Fernández D, Vásquez A, Granadillo V. The Journal of Clinical Investigation. 2007 Sep;48(3):287-94.
Franklin RB, Costello LC. Archives of Biochemistry and Biophysics. 2007 Jul 15;463(2):211-7.
Zaichick VYe, Sviridova TV, Zaichick SV. International Journal of Urology and Nephrology. 1997;29(5):565-74.
Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, Liao J, Lengerich EJ, Berg A, Hartman TJ, Ciccarella A, Baker A, Kaag MG, Goodin S, DiPaola RS, El-Bayoumy K. Cancer Prev Res August 1, 2014 7:796-804
Waters DJ, Shen S, Kengeri SS, et al Nutrients 2012; 4(11):1650-63. doi: 10.3390/nu4111650.
Algotar, A. M., Stratton, M. S., Ahmann, Frederick. R., Ranger-Moore, J., Nagle, R. B., Thompson, P. A., Slate, E., Hsu, C. H., Dalkin, B. L., Sindhwani, P., Holmes, M. A., Tuckey, J. A., Graham, David. L., Parnes, H. L., Clark, L. C. and Stratton, S. P. (2013). Prostate, 73: 328–335.
Li, Zeqin Dong, Chunying Chen, Bai Li, Yuxi Gao, Liya Qu, Tianchen Wang, Xin Fu, Yuliang Zhao, and Zhifang Chai. Environmental Science & Technology 2012 46 (20), 11313-11318
Facompre,N, El-Bayoumy K. “Potential Stages for Prostate Cancer Prevention with Selenium: Implications for Cancer Survivors.” Cancer Research. April 1, 2009 69; 2699.
El-Bayoumy K, Sinha R. “Molecular chemoprevention by selenium: a genomic approach.” Mutation Research. 2005; 591(1-2):224-36.
Duffield-Lillico AJ, Dalkin BL, Reid ME, et al British Journal of Urology International. 2003;91(7):608-12.
El-Bayoumy K, Richie JP Jr, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B, Colosimo S. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1459-65.
Clark LC, Dalkin B, Krongrad A, Combs GF Hr,, Turnbull BW, Slate EH, Witherington R, Herlong J, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J. British Journal of Urology International. May, 1998. Volume 81, Issue 5, pages 730–734.
Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. The Journal of the American Medical Association. 1996 Dec 25;276(24):1957-63.
Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, et AL. Cancer Prev Res (Phila). 2015 Apr 14.
Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, Heber D, Aronson WJ. Prostate. 2015 Apr 1;75(5):550-9.
Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D. Nutrition and Cancer. 2011;63(5):663-72
Butt MS, Sultan MT. Critical Reviews in Food Science and Nutrition. 2009 May;49(5):463-73.
Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. American Journal of Epidemiology. 2008 Jan 1;167(1):71-7.
Brausi M, Rizzi F, Bettuzzi S. Eur Urol. 2008;54:472–473.
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Cancer Research. 2006 Jan 15;66(2):1234-40.
Jian L, Xie LP, Lee AH, Binns CW. International Journal of Cancer. 2004 Jan 1;108(1):130-5.
Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P. International Journal of Cancer. 1998 Dec 9;78(6):707-11.
Wieczorek K, Braczkowski RS, Skrzypek M, Stryjewski PJ, Kuczaj A, Al-Srory G. J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):207-11.
Yalçnkaya S, Eren E2, Eroglu M1, Aydin O3, Yilmaz N3. Advances in Clinical and Experimental Medicine. 2014 May-Jun;23(3):441-6.
Espinosa G, Esposito R, Kazzazi A, Djavan B. The Canadian Journal of Urology. 2013 Aug;20(4):6820-5.
Haghsheno MA, Mellström D, Behre CJ, Damber JE, Johansson H, Karlsson M, Lorentzon M, Peeker R, Barret-Connor E, Waern E, Sundh V, Ohlsson C, Hammarsten J. “Low 25-OH vitamin D is associated with benign prostatic hyperplasia.” The Journal of Urology. 2013 Aug;190(2):608-14.
Gilbert R, Metcalfe C, Oliver SE, Whiteman DC, Bain C, Ness A, et al. Int J Cancer. 2009;125:1414–23
Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. American Journal of Public Health. 2006 Feb;96(2):252-61.
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Int J Cancer. 2004;108:104–8.
Ahonen M, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Cancer Causes & Control. November 2000, Volume 11, Issue 9, pp 847-852.
*The views and opinions expressed by contributors and or product reviews are their own and not
necessarily those of NatureCity. These reviews should not be taken as recommendations but rather
client opinions of the products that they have used.